Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

19-Feb-17 - 17-Feb-18
Buy Ratio:43%

Up

# Net Buyers:119
# Net Sellers:156

Previous 52 Weeks

21-Feb-16 - 18-Feb-17
Buy Ratio:43%
# Net Buyers:141
# Net Sellers:190
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
China Biologic Products, Inc.($14.63M)$1.53B  
Zoetis Inc.($4.30M)$784.61M  
Colucid Pharmaceuticals, Inc.$716.39M$720.88M  
Catalent, Inc.($14.10M)$606.75M  
Relypsa Inc--$140.16M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$716.39M$720.88M  
Acceleron Pharma Inc$21.12M$89.96M  
Merck & Co., Inc.$9.23M$80.93M  
Agios Pharmaceuticals Inc$49.38M$55.42M  
Akorn Inc$38.54M$52.65M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.83B)($1.82B)  
Kite Pharma, Inc.($742.25M)($730.92M)  
Seattle Genetics Inc /wa($18.00M)($251.59M)  
Vertex Pharmaceuticals Inc / Ma($225.23M)($190.56M)  
Bausch Health Companies Inc.($180.66M)($134.57M)  
New Net Sellers
CompanyNet Buy AmountChange
Seattle Genetics Inc /wa($18.00M)($251.59M)  
Incyte Corp($46.07M)($87.13M)  
Abbott Laboratories($53.65M)($84.91M)  
Acadia Pharmaceuticals Inc($7.56M)($78.69M)  
Nexvet Biopharma Plc($76.62M)($78.16M)